Physician profile
Eric Davies
NPI 1427374917
$257,601.73
in general payments reported to CMS, 2019-2025
5 companies · $41K in 2025
The $41K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $6,233 · 2021: $41K · 2022: $56K · 2023: $69K · 2024: $22K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $115K · Food and Beverage: $7,082 · Travel and Lodging: $6,197 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $114,950.00 |
| Food and Beverage | $7,081.90 |
| Travel and Lodging | $6,196.65 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $252,939.65 | 2019-2025 | Da Vinci Surgical System, Davinci Xi, Da Vinci Sp |
| W. L. Gore & Associates, INC. | $4,440.88 | 2022-2024 | Gore Bio-A Tissue Reinforcement, Gore Synecor Biomaterial, Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Ethicon US, LLC | $111.58 | 2024 | Echelon Flex, Monocryl |
| Conmed Corporation | $95.50 | 2025 | Airseal |
| Endo Pharmaceuticals INC. | $14.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Davies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.